Healthcare -
Biotechnology - NASDAQ - US
$ 8.54
-0.813 %
$ 1.78 B
Market Cap
-19.86
P/E
BCRX - COST OF REVENUE
Cost of Revenue BCRX - BioCryst Pharmaceuticals, Inc.
4.66 M
LAST VALUE
-19.90%
2 YEAR CAGR
58.16%
5 YEAR CAGR
47.14%
10 YEAR CAGR